Q1 2020 Holdings
Filed 2020-05-06 | 50 holdings | $415.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cloudflare Inc(NET) | CL A COM | 18915M107 | $95.3M | 4,059,376 | 22.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $91.7M | 16,135,047 | 22.1% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $86.1M | 3,449,845 | 20.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $75.1M | 5,172,683 | 18.1% |
| Adaptimmune Therapeutics PLC(ADAPY) | ADR | 00653A107 | $46.5M | 17,082,611 | 11.2% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $12.7M | 1,713,720 | 3.1% |
| Bloom Energy Corp(BE) | COM CL A | 093712107 | $7.0M | 1,333,333 | 1.7% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $294.7K | 6,138,797 | 0.1% |
| Oyster Point Pharma Inc | COM | 69242L106 | $207.4K | 5,925,287 | 0.0% |
| Sprout Social Inc(SPT) | COM CL A | 85209W109 | $144.4K | 9,046,080 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $100.9K | 2,268,188 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $88.7K | 2,090,678 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $74.8K | 4,912,306 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $69.7K | 11,963,649 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $67.9K | 4,377,518 | 0.0% |
| Imara Inc | COM | 45249V107 | $64.4K | 4,017,170 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $58.6K | 4,187,801 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $41.4K | 4,362,986 | 0.0% |
| Casper Sleep Inc | COM | 147626105 | $26.7K | 6,226,040 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $23.2K | 5,736,363 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $22.0K | 6,643,704 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $20.7K | 9,089,041 | 0.0% |
| Senseonics Holdings Inc(SENS1GBP) | COM | 81727U105 | $18.8K | 29,761,683 | 0.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $14.6K | 4,441,360 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $13.7K | 8,533,072 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM | 372427401 | $12.4K | 7,225,676 | 0.0% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $11.7K | 2,486,062 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.3K | 992,107 | 0.0% |
| Obseva SA | COM | H5861P103 | $11.1K | 4,586,563 | 0.0% |
| Affimed NV | COM | N01045108 | $9.7K | 6,126,488 | 0.0% |
| Marker Therapeutics Inc | COM | 57055L107 | $9.5K | 5,000,000 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $9.3K | 1,766,779 | 0.0% |
| Aveo Pharmaceuticals Inc(0HJQ) | COM | 053588307 | $9.1K | 2,524,387 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $7.8K | 4,141,308 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $7.3K | 4,229,410 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $6.6K | 7,140,450 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $6.2K | 3,315,149 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $5.1K | 3,243,150 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $5.0K | 1,219,674 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $4.6K | 2,382,286 | 0.0% |
| Lumos Pharma Inc | COM | 55028X109 | $4.5K | 526,663 | 0.0% |
| Dasan Zhone Solutions Inc(DZSIEUR) | COM NEW | 23305L206 | $4.0K | 956,255 | 0.0% |
| Erytech Pharma SA | ADR | 29604W108 | $3.3K | 625,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $3.3K | 333,333 | 0.0% |
| Trevena Inc | COM | 89532E109 | $2.2K | 3,811,691 | 0.0% |
| Regulus Therapeutics Inc | COM NEW | 75915K200 | $946 | 2,052,455 | 0.0% |
| Akari Therapeutics PLC | ADR | 00972G108 | $656 | 452,167 | 0.0% |
| Tracon Pharmaceuticals Inc | COM | 89237H209 | $589 | 346,718 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $539 | 1,298,274 | 0.0% |
| Endologix Inc(ELGXEUR) | COM | 29266S304 | $172 | 249,022 | 0.0% |